scorecardresearch
Add as a preferred source on Google
Thursday, October 23, 2025
TopicDrugmakers

Topic: drugmakers

Blockbuster semaglutide set to go off patent, Indian pharma sees a multi-billion-dollar opportunity

Pharma firms are pouncing on opportunity as patents on world’s second-bestselling drug, which goes by brand names Ozempic and Wegovy, are expiring in nearly 100 nations.

Indian drugmakers relieved but wary as US exempts pharma sector from new trade tariffs

Industry insiders say any rise in duties on Indian generics will squeeze profits for Indian companies, but will also make the drugs costlier for patients in US.

Govt relents, relaxes GMP adoption deadline for small, medium pharmas after RSS-backed body weighs in

The proposed extension for drugmakers in adopting Schedule M of Drugs and Cosmetics Act and Rules comes mainly at the behest of RSS-backed Laghu Udyog Bharti, it is learnt.

Indian pharma firms now liable to recall defective drugs as Modi govt notifies new norms

Under revised good manufacturing practices (GMP) norms, pharma companies will be required to assume onus for quality of drugs to ensure they do not place patients at risk.

Reporting faulty manufacture to annual audits: How govt wants drugmakers to improve quality

Nearly 80 percent of small and medium drug manufacturing units in India do not follow good manufacturing practices (GMP) requirements, according to government estimates.

Govt allows existing stock of 14 banned fixed-dose combination drugs to be sold after HC order

Delhi High Court accepted pharma companies’ argument that most banned drugs had been in use for over 30 years and said health ministry had not specified reasons behind ban issued in June.

Govt sets deadline for pharma MSMEs to adopt good manufacturing practices. ‘Follow or be penalised’

Health minister concedes implementation of Schedule M of Drugs and Cosmetics Act has been poor. Timeline for adherence to norms for good manufacturing practices began on 1 August.

Poor documentation, lack of process — Govt finds string of deficiencies among drugmakers after probe

The health ministry has stepped up scrutiny of drugmakers in recent months after some cough syrups made in the country were linked to the deaths of at least 95 children overseas.

Trump is investing millions to bring drug making back to US from India and China

A spike in demand for some drugs & supplies has increased concerns about shortages in the US as 80% of active ingredients come from India, China.

PM Modi warns pharma companies not to bribe doctors with women, foreign trips and gadgets

Modi met senior officials from top drug-makers like Zydus Cadila, Torrent & Wockhardt, and said their non-compliance is forcing govt to create a strict law.

On Camera

Pakistan can’t bend Taliban with bombs. It must stop the Yemen-isation of Durand Line

This confrontation looks subcontracted—escalation to re-establish Pakistan's indispensability to outside capitals while squeezing Afghanistan back under an old paradigm.

Boom to bust: Haunted by Ketan Parekh saga, 117-yr-old Calcutta Stock Exchange’s future lies in limbo

CSE, one of India’s oldest bourses, is edging towards a voluntary exit. It could never recover from market manipulation scam that caused a payment crisis at exchange back in 2001. 

From battle of wits and daring air strikes to artillery fury, new details emerge of Operation Sindoor

Fresh details of operation conducted by IAF, Army have come out in gazette notification giving citations of those who were awarded Vir Chakra for their bravery.

CJI, IPS, IAS & Homebound: A wake-up call 75 years in the making

Education, reservations, govt jobs are meant to bring equality and dignity. That we are a long way from that is evident in the shoe thrown at the CJI and the suicide of Haryana IPS officer. The film Homebound has a lesson too.